Fed. Circ. Urged To Revive Lymphoma Drug Patent Case
Drugmaker Eagle Pharmaceuticals has asked the Federal Circuit to reverse a lower court decision finding that two rivals did not infringe its patent covering cancer drug Belrapzo, arguing that the ruling...To view the full article, register now.
Already a subscriber? Click here to view full article